iRhythm Technologies Inc (IRTC)

iRhythm Technologies Inc stock price live, this page displays NASDAQ IRTC stock exchange data. View the IRTC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the iRhythm Technologies Inc real time stock price chart below.

What Is the iRhythm Technologies Inc Stock Price Today?
The iRhythm Technologies Inc stock price today is 86.43.

What Is the Stock Symbol for iRhythm Technologies Inc?
The stock ticker symbol for iRhythm Technologies Inc is IRTC.

Is IRTC the Same as $IRTC?
$IRTC is a common way to refer to the iRhythm Technologies Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol

What Stock Exchange Does iRhythm Technologies Inc Trade On?
iRhythm Technologies Inc is listed and trades on the NASDAQ stock exchange.

Is iRhythm Technologies Inc a Good Stock to Buy?
Determining whether iRhythm Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current iRhythm Technologies Inc share price compared with the fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRTC quote. (ISIN: US4500561067)

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.